AEMD (STOCKS)
AETHLON MEDICAL INC
$2.990000
+0.060000 (+2.05%)
Prev close: $2.930000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- James B. Frakes, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1.37M
- Employees
- 9
- P/E (TTM)
- -0.07
- P/B (TTM)
- 0.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
4
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q1)
|
$-4.02 | $-0.80 | -3.2193 | -402.06% |
|
Mar 2026 (Q4)
|
$-1.49 | $-2.06 | +0.5613 | +27.31% |
|
Dec 2025 (Q3)
|
$-2.45 | $-2.47 | +0.0184 | +0.75% |
|
Sep 2025 (Q2)
|
$-3.74 | $-3.74 | -0.0034 | -0.09% |
Financial Statements
| Revenues | $759.00 |
| Operating Expenses | $7.08M |
| Research and Development | $1.97M |
| Other Operating Expenses | $5.11M |
| Operating Income/Loss | -$7.08M |
| Income/Loss From Continuing Operations After Tax | -$6.94M |
| Income/Loss From Continuing Operations Before Tax | -$3.30M |
| Net Income/Loss | -$6.94M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$6.94M |
| Net Income/Loss Available To Common Stockholders, Basic | -$6.94M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$9.81 |
| Diluted Earnings Per Share | -$9.81 |
| Basic Average Shares | 1,800,979 |
| Diluted Average Shares | 1,800,979 |
| Assets | $6.24M |
| Current Assets | $5.61M |
| Noncurrent Assets | $624.46K |
| Fixed Assets | $293.11K |
| Other Non-current Assets | $331.35K |
| Liabilities | $1.04M |
| Current Liabilities | $1.04M |
| Accounts Payable | $411.37K |
| Other Current Liabilities | $624.67K |
| Noncurrent Liabilities | $0.00 |
| Equity | $5.20M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.20M |
| Liabilities And Equity | $6.24M |
| Net Cash Flow From Operating Activities | -$7.18M |
| Net Cash Flow From Operating Activities, Continuing | -$7.18M |
| Net Cash Flow From Investing Activities | -$1.75M |
| Net Cash Flow From Investing Activities, Continuing | -$1.73M |
| Net Cash Flow From Financing Activities | $8.34M |
| Net Cash Flow From Financing Activities, Continuing | $8.34M |
| Exchange Gains/Losses | $17.88K |
| Net Cash Flow | -$581.84K |
| Net Cash Flow, Continuing | -$599.72K |
| Other Comprehensive Income/Loss | -$29.22K |